Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Aki Morikawa
Phase I Study of Intermittent High Dose Lapatinib Alternating With Capecitabine for HER2-positive Breast Cancer Patients With Central Nervous System Metastases
Clinical Cancer Research
Cancer Research
Oncology
Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis
Clinical Breast Cancer
Cancer Research
Oncology
Related publications
HER2-positive Breast Cancer With Brain Metastasis, Long Responder to Lapatinib Therapy
AboutOpen
Risk Factors for the Development of Brain Metastases in Patients With HER2-positive Breast Cancer
ESMO Open
Cancer Research
Oncology
Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-Negative HER2-Overexpressed Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
Phase I Dose-Finding Study of Eribulin and Capecitabine for Metastatic Breast Cancer: JBCRG-18 Cape Study
Breast Cancer
Nuclear Medicine
Radiology
Pharmacology
Oncology
Imaging
Medicine
BioPATH: A Biomarker Study in Asian Patients With HER2+ Advanced Breast Cancer Treated With Lapatinib and Other Anti-Her2 Therapy
Cancer Research and Treatment
Cancer Research
Oncology
Patient With Metastatic Breast Cancer, HER2-positive, Trastuzumab- And Pertuzumab-Resistant Responding to Lapatinib
AboutOpen
Lapatinib Plus Capecitabine in Women With HER-2-Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial
Oncologist
Cancer Research
Medicine
Oncology
Lapatinib Plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) Experience
Breast Care
Surgery
Oncology
